Lipid Expert and Babraham Institute Director Michael Wakelam Dies

Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Babraham Institute Director Michael Wakelam died on March 31 due to respiratory complications from a suspected COVID-19 infection, according to the Babraham Institute. He was 64 years old.

Over the course of his research career, Wakelam investigated cell signaling and communication with a focus on the physiological functions of lipids, according to the Babraham Institute, where he had served as director since 2007. His lab pioneered high-sensitivity liquid chromatography-mass spectrometry (LC-MS) technology that allowed researchers to measure lipid levels in different types of cells, tissues, and tumors, and sought to understand the role that lipids play in cell function during the process of aging.

Wakelam earned an undergraduate degree in medical biochemistry in 1977 and a PhD in biochemistry in 1980, both from the University of Birmingham, according to the Babraham Institute. He then completed postdocs at the University of Konstanz in Germany and Imperial College London. In 1985, Wakelam ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies